

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 4.93060304 |
| 2 | mitotic chromosome condensation (GO:0007076) | 4.38887087 |
| 3 | protein maturation by protein folding (GO:0022417) | 4.19322656 |
| 4 | establishment of integrated proviral latency (GO:0075713) | 4.14990650 |
| 5 | regulation of translational fidelity (GO:0006450) | 4.08226712 |
| 6 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 4.02159509 |
| 7 | maturation of SSU-rRNA (GO:0030490) | 4.00626715 |
| 8 | ribosomal small subunit assembly (GO:0000028) | 3.98084581 |
| 9 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.91573573 |
| 10 | proline biosynthetic process (GO:0006561) | 3.90796495 |
| 11 | proteasome assembly (GO:0043248) | 3.86551791 |
| 12 | regulation of translational termination (GO:0006449) | 3.85839371 |
| 13 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.84148511 |
| 14 | DNA replication checkpoint (GO:0000076) | 3.76329463 |
| 15 | mitotic sister chromatid segregation (GO:0000070) | 3.76105012 |
| 16 | DNA strand elongation (GO:0022616) | 3.73568142 |
| 17 | regulation of mitochondrial translation (GO:0070129) | 3.73155534 |
| 18 | formation of translation preinitiation complex (GO:0001731) | 3.71817756 |
| 19 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.71577513 |
| 20 | ribosome biogenesis (GO:0042254) | 3.68729960 |
| 21 | DNA replication initiation (GO:0006270) | 3.66993083 |
| 22 | heterochromatin organization (GO:0070828) | 3.65950306 |
| 23 | ribosomal large subunit biogenesis (GO:0042273) | 3.57730183 |
| 24 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.55789332 |
| 25 | nucleobase biosynthetic process (GO:0046112) | 3.54031268 |
| 26 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.47018327 |
| 27 | mitotic metaphase plate congression (GO:0007080) | 3.45312161 |
| 28 | ribosome assembly (GO:0042255) | 3.43727089 |
| 29 | transcription from mitochondrial promoter (GO:0006390) | 3.43378296 |
| 30 | rRNA transcription (GO:0009303) | 3.42874309 |
| 31 | protein complex localization (GO:0031503) | 3.41662241 |
| 32 | purine nucleobase biosynthetic process (GO:0009113) | 3.41547624 |
| 33 | viral transcription (GO:0019083) | 3.40369706 |
| 34 | nuclear pore complex assembly (GO:0051292) | 3.38131037 |
| 35 | negative regulation of mRNA processing (GO:0050686) | 3.37570855 |
| 36 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.35930180 |
| 37 | ribosomal small subunit biogenesis (GO:0042274) | 3.35656312 |
| 38 | establishment of viral latency (GO:0019043) | 3.35486843 |
| 39 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.34184643 |
| 40 | telomere maintenance via recombination (GO:0000722) | 3.33866014 |
| 41 | translational termination (GO:0006415) | 3.33493559 |
| 42 | COPI coating of Golgi vesicle (GO:0048205) | 3.31893649 |
| 43 | Golgi transport vesicle coating (GO:0048200) | 3.31893649 |
| 44 | rRNA processing (GO:0006364) | 3.26008243 |
| 45 | sister chromatid segregation (GO:0000819) | 3.22755303 |
| 46 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 3.21939277 |
| 47 | IMP biosynthetic process (GO:0006188) | 3.20813940 |
| 48 | spliceosomal snRNP assembly (GO:0000387) | 3.18550654 |
| 49 | negative regulation of RNA splicing (GO:0033119) | 3.17159593 |
| 50 | rRNA metabolic process (GO:0016072) | 3.15223462 |
| 51 | translational initiation (GO:0006413) | 3.14841680 |
| 52 | negative regulation of mRNA metabolic process (GO:1903312) | 3.12463137 |
| 53 | DNA unwinding involved in DNA replication (GO:0006268) | 3.12067574 |
| 54 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.09232188 |
| 55 | pseudouridine synthesis (GO:0001522) | 3.07636765 |
| 56 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 3.07394918 |
| 57 | mitotic nuclear envelope reassembly (GO:0007084) | 3.07120197 |
| 58 | nuclear envelope reassembly (GO:0031468) | 3.07120197 |
| 59 | translational elongation (GO:0006414) | 3.06580750 |
| 60 | protein localization to kinetochore (GO:0034501) | 3.06442803 |
| 61 | mitotic recombination (GO:0006312) | 3.05243706 |
| 62 | telomere maintenance via telomere lengthening (GO:0010833) | 3.05158251 |
| 63 | termination of RNA polymerase III transcription (GO:0006386) | 3.04211609 |
| 64 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.04211609 |
| 65 | mitotic nuclear envelope disassembly (GO:0007077) | 3.01569434 |
| 66 | rRNA modification (GO:0000154) | 3.01455754 |
| 67 | nuclear pore organization (GO:0006999) | 3.01237111 |
| 68 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 3.00647259 |
| 69 | histone arginine methylation (GO:0034969) | 2.98932179 |
| 70 | tRNA methylation (GO:0030488) | 2.98534639 |
| 71 | cellular protein complex localization (GO:0034629) | 2.97641298 |
| 72 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.97425147 |
| 73 | chromatin remodeling at centromere (GO:0031055) | 2.95613346 |
| 74 | CENP-A containing nucleosome assembly (GO:0034080) | 2.95123062 |
| 75 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.93686284 |
| 76 | tRNA aminoacylation for protein translation (GO:0006418) | 2.92424263 |
| 77 | kinetochore assembly (GO:0051382) | 2.92093943 |
| 78 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.91764656 |
| 79 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.91757949 |
| 80 | mitochondrial RNA metabolic process (GO:0000959) | 2.88057978 |
| 81 | metaphase plate congression (GO:0051310) | 2.87295826 |
| 82 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.87187586 |
| 83 | chromosome condensation (GO:0030261) | 2.86313309 |
| 84 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.86275003 |
| 85 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.85504581 |
| 86 | kinetochore organization (GO:0051383) | 2.84815960 |
| 87 | amino acid activation (GO:0043038) | 2.84355198 |
| 88 | tRNA aminoacylation (GO:0043039) | 2.84355198 |
| 89 | protein targeting to mitochondrion (GO:0006626) | 2.84123683 |
| 90 | protein targeting to ER (GO:0045047) | 2.82913351 |
| 91 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.82860752 |
| 92 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.82814371 |
| 93 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.82504585 |
| 94 | cotranslational protein targeting to membrane (GO:0006613) | 2.82322692 |
| 95 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.80974888 |
| 96 | IMP metabolic process (GO:0046040) | 2.77868980 |
| 97 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.77006694 |
| 98 | peptidyl-arginine methylation (GO:0018216) | 2.76748788 |
| 99 | peptidyl-arginine N-methylation (GO:0035246) | 2.76748788 |
| 100 | pyrimidine ribonucleoside triphosphate metabolic process (GO:0009208) | 2.76506952 |
| 101 | transcription from RNA polymerase I promoter (GO:0006360) | 2.76446274 |
| 102 | folic acid metabolic process (GO:0046655) | 2.75671734 |
| 103 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.72390750 |
| 104 | UTP biosynthetic process (GO:0006228) | 2.72382948 |
| 105 | mRNA splicing, via spliceosome (GO:0000398) | 2.71628549 |
| 106 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377) | 2.71628549 |
| 107 | nuclear envelope disassembly (GO:0051081) | 2.71592230 |
| 108 | membrane disassembly (GO:0030397) | 2.71592230 |
| 109 | positive regulation of chromosome segregation (GO:0051984) | 2.71276053 |
| 110 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 2.70128565 |
| 111 | regulation of translational elongation (GO:0006448) | 2.69873133 |
| 112 | protein localization to chromosome, centromeric region (GO:0071459) | 2.69859952 |
| 113 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.69469037 |
| 114 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.69469037 |
| 115 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.69469037 |
| 116 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.69015550 |
| 117 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.68533042 |
| 118 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.68533042 |
| 119 | translation (GO:0006412) | 2.68225734 |
| 120 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 2.67721359 |
| 121 | termination of RNA polymerase I transcription (GO:0006363) | 2.66626587 |
| 122 | viral life cycle (GO:0019058) | 2.65952097 |
| 123 | establishment of chromosome localization (GO:0051303) | 2.65849167 |
| 124 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.65797889 |
| 125 | cell cycle G1/S phase transition (GO:0044843) | 2.65797889 |
| 126 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.65748910 |
| 127 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.65748910 |
| 128 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.64988011 |
| 129 | negative regulation of ligase activity (GO:0051352) | 2.64241654 |
| 130 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.64241654 |
| 131 | protein localization to endoplasmic reticulum (GO:0070972) | 2.63301459 |
| 132 | immunoglobulin mediated immune response (GO:0016064) | 2.62910355 |
| 133 | DNA replication-independent nucleosome organization (GO:0034724) | 2.62371718 |
| 134 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.62371718 |
| 135 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.61914228 |
| 136 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.61460512 |
| 137 | cellular protein complex disassembly (GO:0043624) | 2.59426308 |
| 138 | 7-methylguanosine mRNA capping (GO:0006370) | 2.57976409 |
| 139 | regulation of spindle organization (GO:0090224) | 2.57976393 |
| 140 | maturation of 5.8S rRNA (GO:0000460) | 2.57460698 |
| 141 | cellular component biogenesis (GO:0044085) | 2.57164250 |
| 142 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.56537256 |
| 143 | DNA-dependent DNA replication (GO:0006261) | 2.55887708 |
| 144 | 7-methylguanosine RNA capping (GO:0009452) | 2.54985132 |
| 145 | RNA capping (GO:0036260) | 2.54985132 |
| 146 | B cell mediated immunity (GO:0019724) | 2.52548559 |
| 147 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.50521842 |
| 148 | viral mRNA export from host cell nucleus (GO:0046784) | 2.49724362 |
| 149 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.49121285 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.38407982 |
| 2 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.11441492 |
| 3 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.50172988 |
| 4 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.11870131 |
| 5 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.98399704 |
| 6 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.94627121 |
| 7 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.93372445 |
| 8 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.91513002 |
| 9 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.88763263 |
| 10 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.79862330 |
| 11 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.79698269 |
| 12 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.76529926 |
| 13 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.73948814 |
| 14 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.65975932 |
| 15 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.54089612 |
| 16 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.38722654 |
| 17 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.18900359 |
| 18 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.15370863 |
| 19 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.14773325 |
| 20 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.10598554 |
| 21 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.09904811 |
| 22 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.05709853 |
| 23 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.05412432 |
| 24 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.03910793 |
| 25 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.01608084 |
| 26 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.99110169 |
| 27 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.93278624 |
| 28 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.89293392 |
| 29 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.85355118 |
| 30 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.85172046 |
| 31 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.83708635 |
| 32 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.83157404 |
| 33 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.81437744 |
| 34 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.81279094 |
| 35 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.73432918 |
| 36 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.73397404 |
| 37 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.69653749 |
| 38 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68270059 |
| 39 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.66145260 |
| 40 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.65728067 |
| 41 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.65555981 |
| 42 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.65040502 |
| 43 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64172938 |
| 44 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.63750011 |
| 45 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.63169353 |
| 46 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.61881584 |
| 47 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.60701034 |
| 48 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.56870495 |
| 49 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.56424668 |
| 50 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.55154116 |
| 51 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.54654040 |
| 52 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.54426620 |
| 53 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.51034851 |
| 54 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.50573718 |
| 55 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48727652 |
| 56 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.45112629 |
| 57 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.44673746 |
| 58 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.44643010 |
| 59 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.41998385 |
| 60 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.41995499 |
| 61 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.41781454 |
| 62 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.40698643 |
| 63 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.38080971 |
| 64 | MYC_22102868_ChIP-Seq_BL_Human | 1.33923892 |
| 65 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 1.30016481 |
| 66 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.29260557 |
| 67 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.27520137 |
| 68 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.27166653 |
| 69 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.26489345 |
| 70 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.25858459 |
| 71 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.25313995 |
| 72 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.23660508 |
| 73 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.22923106 |
| 74 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.20036248 |
| 75 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.19040665 |
| 76 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.17787003 |
| 77 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.16815605 |
| 78 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.15662893 |
| 79 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.15337481 |
| 80 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.14082954 |
| 81 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.12852726 |
| 82 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.11623017 |
| 83 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.10355016 |
| 84 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.09753106 |
| 85 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.07794867 |
| 86 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.07264100 |
| 87 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.06944189 |
| 88 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.06156854 |
| 89 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.05823542 |
| 90 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.05339038 |
| 91 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.05337365 |
| 92 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.05053187 |
| 93 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.03996809 |
| 94 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.03918241 |
| 95 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.02609250 |
| 96 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.01627001 |
| 97 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.01569360 |
| 98 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.01141311 |
| 99 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00957213 |
| 100 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.00857797 |
| 101 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.98544247 |
| 102 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.98257760 |
| 103 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.97900444 |
| 104 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.97869935 |
| 105 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.97494749 |
| 106 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.96827958 |
| 107 | * CHD1_26751641_Chip-Seq_LNCaP_Human | 0.96356446 |
| 108 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.95427017 |
| 109 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.95304083 |
| 110 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.93531595 |
| 111 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.92645113 |
| 112 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.92504721 |
| 113 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.91601307 |
| 114 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.91380538 |
| 115 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.89769671 |
| 116 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.89452625 |
| 117 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.89069824 |
| 118 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.87952520 |
| 119 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.87877980 |
| 120 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.87075684 |
| 121 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84105859 |
| 122 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.83669590 |
| 123 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.79487585 |
| 124 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.79385584 |
| 125 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.79004325 |
| 126 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.78872066 |
| 127 | MYB_26560356_Chip-Seq_TH1_Human | 0.77064698 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 4.82696320 |
| 2 | MP0003111_abnormal_nucleus_morphology | 3.53932210 |
| 3 | MP0010094_abnormal_chromosome_stability | 3.33839949 |
| 4 | MP0004957_abnormal_blastocyst_morpholog | 3.18935497 |
| 5 | MP0008057_abnormal_DNA_replication | 3.13010800 |
| 6 | MP0003077_abnormal_cell_cycle | 3.09997388 |
| 7 | MP0008058_abnormal_DNA_repair | 2.87433940 |
| 8 | MP0005451_abnormal_body_composition | 2.74736122 |
| 9 | MP0002877_abnormal_melanocyte_morpholog | 2.67874895 |
| 10 | MP0008007_abnormal_cellular_replicative | 2.50970563 |
| 11 | MP0000678_abnormal_parathyroid_gland | 2.47664317 |
| 12 | MP0001835_abnormal_antigen_presentation | 2.43533563 |
| 13 | MP0002396_abnormal_hematopoietic_system | 2.23813897 |
| 14 | MP0009333_abnormal_splenocyte_physiolog | 2.12692426 |
| 15 | MP0003436_decreased_susceptibility_to | 2.10342567 |
| 16 | MP0008932_abnormal_embryonic_tissue | 2.08914648 |
| 17 | MP0004233_abnormal_muscle_weight | 2.08393183 |
| 18 | MP0009785_altered_susceptibility_to | 2.05525723 |
| 19 | MP0003705_abnormal_hypodermis_morpholog | 1.96638960 |
| 20 | MP0000490_abnormal_crypts_of | 1.85631478 |
| 21 | MP0002148_abnormal_hypersensitivity_rea | 1.84010405 |
| 22 | MP0003786_premature_aging | 1.73199040 |
| 23 | MP0001853_heart_inflammation | 1.72837693 |
| 24 | MP0010352_gastrointestinal_tract_polyps | 1.67650671 |
| 25 | MP0005501_abnormal_skin_physiology | 1.67627968 |
| 26 | MP0002796_impaired_skin_barrier | 1.67602398 |
| 27 | MP0004185_abnormal_adipocyte_glucose | 1.67417887 |
| 28 | MP0005000_abnormal_immune_tolerance | 1.62409948 |
| 29 | MP0000858_altered_metastatic_potential | 1.61422461 |
| 30 | MP0010307_abnormal_tumor_latency | 1.61026484 |
| 31 | MP0000350_abnormal_cell_proliferation | 1.60409399 |
| 32 | MP0005025_abnormal_response_to | 1.59694278 |
| 33 | MP0002452_abnormal_antigen_presenting | 1.58035138 |
| 34 | MP0003315_abnormal_perineum_morphology | 1.56905514 |
| 35 | MP0001730_embryonic_growth_arrest | 1.54476690 |
| 36 | MP0005623_abnormal_meninges_morphology | 1.53858917 |
| 37 | MP0005671_abnormal_response_to | 1.51829742 |
| 38 | MP0009672_abnormal_birth_weight | 1.49858616 |
| 39 | MP0002419_abnormal_innate_immunity | 1.49494433 |
| 40 | MP0002723_abnormal_immune_serum | 1.49160208 |
| 41 | MP0001800_abnormal_humoral_immune | 1.49129933 |
| 42 | MP0001545_abnormal_hematopoietic_system | 1.46253732 |
| 43 | MP0005397_hematopoietic_system_phenotyp | 1.46253732 |
| 44 | MP0000537_abnormal_urethra_morphology | 1.45542401 |
| 45 | MP0000685_abnormal_immune_system | 1.45235182 |
| 46 | MP0006082_CNS_inflammation | 1.44139192 |
| 47 | MP0010234_abnormal_vibrissa_follicle | 1.43904862 |
| 48 | MP0003718_maternal_effect | 1.43831373 |
| 49 | MP0002398_abnormal_bone_marrow | 1.43525321 |
| 50 | MP0001661_extended_life_span | 1.43008136 |
| 51 | MP0006036_abnormal_mitochondrial_physio | 1.42744060 |
| 52 | MP0003763_abnormal_thymus_physiology | 1.40666278 |
| 53 | MP0003186_abnormal_redox_activity | 1.40093430 |
| 54 | MP0002405_respiratory_system_inflammati | 1.38436674 |
| 55 | MP0000313_abnormal_cell_death | 1.36581600 |
| 56 | MP0003941_abnormal_skin_development | 1.35730289 |
| 57 | MP0003566_abnormal_cell_adhesion | 1.35294883 |
| 58 | * MP0001819_abnormal_immune_cell | 1.35008069 |
| 59 | MP0006035_abnormal_mitochondrial_morpho | 1.34798109 |
| 60 | MP0002019_abnormal_tumor_incidence | 1.34267145 |
| 61 | * MP0002420_abnormal_adaptive_immunity | 1.33565268 |
| 62 | MP0000689_abnormal_spleen_morphology | 1.31201610 |
| 63 | MP0002722_abnormal_immune_system | 1.30021145 |
| 64 | MP0003724_increased_susceptibility_to | 1.29138706 |
| 65 | MP0002132_abnormal_respiratory_system | 1.27490999 |
| 66 | MP0001790_abnormal_immune_system | 1.27297005 |
| 67 | MP0005387_immune_system_phenotype | 1.27297005 |
| 68 | MP0004808_abnormal_hematopoietic_stem | 1.23865117 |
| 69 | * MP0000716_abnormal_immune_system | 1.23645381 |
| 70 | MP0003448_altered_tumor_morphology | 1.22319500 |
| 71 | * MP0002429_abnormal_blood_cell | 1.20550101 |
| 72 | MP0001672_abnormal_embryogenesis/_devel | 1.19400983 |
| 73 | MP0005380_embryogenesis_phenotype | 1.19400983 |
| 74 | MP0001849_ear_inflammation | 1.19171038 |
| 75 | MP0005058_abnormal_lysosome_morphology | 1.17571557 |
| 76 | MP0009697_abnormal_copulation | 1.16940821 |
| 77 | MP0008877_abnormal_DNA_methylation | 1.15199369 |
| 78 | MP0000703_abnormal_thymus_morphology | 1.11779330 |
| 79 | MP0009053_abnormal_anal_canal | 1.10891024 |
| 80 | MP0000003_abnormal_adipose_tissue | 1.09705323 |
| 81 | MP0002163_abnormal_gland_morphology | 1.09619279 |
| 82 | MP0001346_abnormal_lacrimal_gland | 1.08309099 |
| 83 | MP0002277_abnormal_respiratory_mucosa | 1.06585751 |
| 84 | MP0003984_embryonic_growth_retardation | 1.06305880 |
| 85 | MP0003123_paternal_imprinting | 1.06201599 |
| 86 | MP0001697_abnormal_embryo_size | 1.05328753 |
| 87 | * MP0002080_prenatal_lethality | 1.04714944 |
| 88 | MP0002060_abnormal_skin_morphology | 1.04710685 |
| 89 | MP0002088_abnormal_embryonic_growth/wei | 1.02537120 |
| 90 | MP0005330_cardiomyopathy | 0.98728802 |
| 91 | MP0010155_abnormal_intestine_physiology | 0.98532285 |
| 92 | MP0004197_abnormal_fetal_growth/weight/ | 0.97600531 |
| 93 | MP0001845_abnormal_inflammatory_respons | 0.96145500 |
| 94 | MP0001533_abnormal_skeleton_physiology | 0.95694231 |
| 95 | MP0004272_abnormal_basement_membrane | 0.94802880 |
| 96 | MP0001881_abnormal_mammary_gland | 0.89993836 |
| 97 | MP0005174_abnormal_tail_pigmentation | 0.89327591 |
| 98 | MP0001293_anophthalmia | 0.88777694 |
| 99 | MP0002086_abnormal_extraembryonic_tissu | 0.88138875 |
| 100 | MP0005076_abnormal_cell_differentiation | 0.88088388 |
| 101 | MP0002085_abnormal_embryonic_tissue | 0.87801954 |
| 102 | MP0002210_abnormal_sex_determination | 0.87387051 |
| 103 | MP0002089_abnormal_postnatal_growth/wei | 0.86323459 |
| 104 | MP0004858_abnormal_nervous_system | 0.86238410 |
| 105 | MP0002160_abnormal_reproductive_system | 0.85724267 |
| 106 | MP0005464_abnormal_platelet_physiology | 0.85541212 |
| 107 | MP0006292_abnormal_olfactory_placode | 0.84354101 |
| 108 | MP0002249_abnormal_larynx_morphology | 0.84169637 |
| 109 | MP0008260_abnormal_autophagy | 0.83947008 |
| 110 | MP0008469_abnormal_protein_level | 0.83597323 |
| 111 | MP0000762_abnormal_tongue_morphology | 0.83050365 |
| 112 | MP0009278_abnormal_bone_marrow | 0.82590721 |
| 113 | MP0005257_abnormal_intraocular_pressure | 0.82128742 |
| 114 | MP0003453_abnormal_keratinocyte_physiol | 0.82056727 |
| 115 | MP0000733_abnormal_muscle_development | 0.81980625 |
| 116 | MP0002006_tumorigenesis | 0.81628129 |
| 117 | MP0003942_abnormal_urinary_system | 0.80901154 |
| 118 | MP0005023_abnormal_wound_healing | 0.80363310 |
| 119 | MP0002933_joint_inflammation | 0.79046051 |
| 120 | MP0003567_abnormal_fetal_cardiomyocyte | 0.78358851 |
| 121 | MP0001727_abnormal_embryo_implantation | 0.78072747 |
| 122 | MP0003303_peritoneal_inflammation | 0.77195027 |
| 123 | MP0000343_altered_response_to | 0.77150426 |
| 124 | MP0001216_abnormal_epidermal_layer | 0.76771334 |
| 125 | MP0001119_abnormal_female_reproductive | 0.75627454 |
| 126 | MP0004947_skin_inflammation | 0.73494815 |
| 127 | MP0005390_skeleton_phenotype | 0.73019709 |
| 128 | MP0000750_abnormal_muscle_regeneration | 0.72883006 |
| 129 | MP0009764_decreased_sensitivity_to | 0.72100928 |
| 130 | MP0002697_abnormal_eye_size | 0.72053576 |
| 131 | MP0005621_abnormal_cell_physiology | 0.71957806 |
| 132 | MP0002111_abnormal_tail_morphology | 0.71707838 |
| 133 | MP0001145_abnormal_male_reproductive | 0.71561363 |
| 134 | MP0000627_abnormal_mammary_gland | 0.71233997 |
| 135 | MP0002269_muscular_atrophy | 0.70999656 |
| 136 | MP0005375_adipose_tissue_phenotype | 0.70157915 |
| 137 | MP0003828_pulmonary_edema | 0.70106346 |
| 138 | MP0009379_abnormal_foot_pigmentation | 0.68588999 |
| 139 | MP0005666_abnormal_adipose_tissue | 0.67836306 |
| 140 | MP0005379_endocrine/exocrine_gland_phen | 0.67585269 |
| 141 | MP0002084_abnormal_developmental_patter | 0.67377480 |
| 142 | MP0003385_abnormal_body_wall | 0.67373903 |
| 143 | MP0000358_abnormal_cell_content/ | 0.66776206 |
| 144 | MP0010030_abnormal_orbit_morphology | 0.66509183 |
| 145 | MP0005384_cellular_phenotype | 0.65035664 |
| 146 | MP0003806_abnormal_nucleotide_metabolis | 0.64711458 |
| 147 | MP0000467_abnormal_esophagus_morphology | 0.64198379 |
| 148 | MP0001915_intracranial_hemorrhage | 0.63713122 |
| 149 | MP0000759_abnormal_skeletal_muscle | 0.63402051 |
| 150 | MP0008438_abnormal_cutaneous_collagen | 0.63288917 |
| 151 | MP0005075_abnormal_melanosome_morpholog | 0.62870993 |
| 152 | MP0000747_muscle_weakness | 0.62259377 |
| 153 | MP0005670_abnormal_white_adipose | 0.61819834 |
| 154 | MP0009250_abnormal_appendicular_skeleto | 0.60931028 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Birth length less than 3rd percentile (HP:0003561) | 4.35921172 |
| 2 | Progressive muscle weakness (HP:0003323) | 4.34860364 |
| 3 | Reticulocytopenia (HP:0001896) | 3.97910146 |
| 4 | Chromsome breakage (HP:0040012) | 3.69416135 |
| 5 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.68801112 |
| 6 | Microvesicular hepatic steatosis (HP:0001414) | 3.68364354 |
| 7 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.63528828 |
| 8 | Abnormal number of erythroid precursors (HP:0012131) | 3.53519063 |
| 9 | Ragged-red muscle fibers (HP:0003200) | 3.37510914 |
| 10 | Breast hypoplasia (HP:0003187) | 3.32419439 |
| 11 | Rough bone trabeculation (HP:0100670) | 3.21670510 |
| 12 | Recurrent abscess formation (HP:0002722) | 3.19171568 |
| 13 | Oral leukoplakia (HP:0002745) | 3.09055057 |
| 14 | Eczematoid dermatitis (HP:0000976) | 3.07682339 |
| 15 | Abnormality of glycolysis (HP:0004366) | 2.99773725 |
| 16 | Aplastic anemia (HP:0001915) | 2.99054788 |
| 17 | Degeneration of anterior horn cells (HP:0002398) | 2.95210731 |
| 18 | Abnormality of the anterior horn cell (HP:0006802) | 2.95210731 |
| 19 | Poor head control (HP:0002421) | 2.93263950 |
| 20 | Pallor (HP:0000980) | 2.92650380 |
| 21 | Testicular atrophy (HP:0000029) | 2.86524787 |
| 22 | Recurrent bacterial skin infections (HP:0005406) | 2.84965028 |
| 23 | Premature graying of hair (HP:0002216) | 2.73046497 |
| 24 | Trismus (HP:0000211) | 2.72630967 |
| 25 | Agnosia (HP:0010524) | 2.70123007 |
| 26 | Meckel diverticulum (HP:0002245) | 2.69608615 |
| 27 | Patellar aplasia (HP:0006443) | 2.63987633 |
| 28 | Absent thumb (HP:0009777) | 2.63467654 |
| 29 | Abnormality of the umbilical cord (HP:0010881) | 2.62591982 |
| 30 | Macrocytic anemia (HP:0001972) | 2.62274994 |
| 31 | Increased serum pyruvate (HP:0003542) | 2.60962854 |
| 32 | Hyperacusis (HP:0010780) | 2.60647943 |
| 33 | Achilles tendon contracture (HP:0001771) | 2.60422218 |
| 34 | Abnormality of the preputium (HP:0100587) | 2.58903366 |
| 35 | Carpal bone hypoplasia (HP:0001498) | 2.58030910 |
| 36 | Abnormality of the ileum (HP:0001549) | 2.55548912 |
| 37 | Mediastinal lymphadenopathy (HP:0100721) | 2.53334848 |
| 38 | Cleft eyelid (HP:0000625) | 2.52588187 |
| 39 | Bone marrow hypocellularity (HP:0005528) | 2.51658283 |
| 40 | Abnormal trabecular bone morphology (HP:0100671) | 2.50861226 |
| 41 | Cerebral hypomyelination (HP:0006808) | 2.48733098 |
| 42 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.48629101 |
| 43 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.44836224 |
| 44 | Abnormality of chromosome stability (HP:0003220) | 2.42411803 |
| 45 | Multiple enchondromatosis (HP:0005701) | 2.38203185 |
| 46 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.36207234 |
| 47 | Glossoptosis (HP:0000162) | 2.35268714 |
| 48 | Premature rupture of membranes (HP:0001788) | 2.34562321 |
| 49 | Obstructive lung disease (HP:0006536) | 2.34535363 |
| 50 | Chronic obstructive pulmonary disease (HP:0006510) | 2.34535363 |
| 51 | Squamous cell carcinoma (HP:0002860) | 2.32600525 |
| 52 | Thrombocytosis (HP:0001894) | 2.32278458 |
| 53 | Abnormal gallbladder physiology (HP:0012438) | 2.32239775 |
| 54 | Cholecystitis (HP:0001082) | 2.32239775 |
| 55 | Septate vagina (HP:0001153) | 2.32151346 |
| 56 | Unilateral renal agenesis (HP:0000122) | 2.30983730 |
| 57 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.30485758 |
| 58 | 11 pairs of ribs (HP:0000878) | 2.29282427 |
| 59 | Abnormality of the Achilles tendon (HP:0005109) | 2.28329340 |
| 60 | Pulmonary fibrosis (HP:0002206) | 2.27501424 |
| 61 | Insomnia (HP:0100785) | 2.24350079 |
| 62 | Progressive external ophthalmoplegia (HP:0000590) | 2.23792300 |
| 63 | Type I transferrin isoform profile (HP:0003642) | 2.23588152 |
| 64 | Myelodysplasia (HP:0002863) | 2.22263374 |
| 65 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.21849221 |
| 66 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.21849221 |
| 67 | Single umbilical artery (HP:0001195) | 2.21849221 |
| 68 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.20011688 |
| 69 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.20011688 |
| 70 | Microretrognathia (HP:0000308) | 2.19701993 |
| 71 | Abnormality of macrophages (HP:0004311) | 2.19421777 |
| 72 | Deviation of the thumb (HP:0009603) | 2.19378603 |
| 73 | Proximal placement of thumb (HP:0009623) | 2.17923168 |
| 74 | Selective tooth agenesis (HP:0001592) | 2.17868041 |
| 75 | Truncus arteriosus (HP:0001660) | 2.17446821 |
| 76 | Tracheoesophageal fistula (HP:0002575) | 2.15913834 |
| 77 | Secondary amenorrhea (HP:0000869) | 2.15469704 |
| 78 | Lymphoma (HP:0002665) | 2.13292880 |
| 79 | Absent radius (HP:0003974) | 2.13064726 |
| 80 | Basal ganglia calcification (HP:0002135) | 2.12757101 |
| 81 | Pancytopenia (HP:0001876) | 2.10506463 |
| 82 | Reduced antithrombin III activity (HP:0001976) | 2.09647169 |
| 83 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.08303891 |
| 84 | Cellular immunodeficiency (HP:0005374) | 2.06619084 |
| 85 | Broad distal phalanx of finger (HP:0009836) | 2.06336294 |
| 86 | Irregular epiphyses (HP:0010582) | 2.05014142 |
| 87 | Ectopic kidney (HP:0000086) | 2.04401293 |
| 88 | Stenosis of the external auditory canal (HP:0000402) | 2.04292249 |
| 89 | Premature ovarian failure (HP:0008209) | 2.03964458 |
| 90 | Petechiae (HP:0000967) | 2.03403092 |
| 91 | Generalized amyotrophy (HP:0003700) | 2.02167726 |
| 92 | Stomatitis (HP:0010280) | 2.02040670 |
| 93 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.01510263 |
| 94 | Triphalangeal thumb (HP:0001199) | 1.99945679 |
| 95 | Increased nuchal translucency (HP:0010880) | 1.99429894 |
| 96 | Autoimmune thrombocytopenia (HP:0001973) | 1.98929745 |
| 97 | Hypokinesia (HP:0002375) | 1.97857241 |
| 98 | Long palpebral fissure (HP:0000637) | 1.97732813 |
| 99 | Nausea (HP:0002018) | 1.97083563 |
| 100 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.97069094 |
| 101 | Sparse lateral eyebrow (HP:0005338) | 1.95626915 |
| 102 | Duplicated collecting system (HP:0000081) | 1.94969446 |
| 103 | Vertebral compression fractures (HP:0002953) | 1.94861157 |
| 104 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.94666775 |
| 105 | Hypergonadotropic hypogonadism (HP:0000815) | 1.94263764 |
| 106 | Increased IgM level (HP:0003496) | 1.93737449 |
| 107 | Impulsivity (HP:0100710) | 1.92954421 |
| 108 | Increased serum lactate (HP:0002151) | 1.91688318 |
| 109 | Aplasia involving forearm bones (HP:0009822) | 1.91609306 |
| 110 | Absent forearm bone (HP:0003953) | 1.91609306 |
| 111 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.90447099 |
| 112 | Breech presentation (HP:0001623) | 1.90237404 |
| 113 | Duodenal stenosis (HP:0100867) | 1.89501787 |
| 114 | Small intestinal stenosis (HP:0012848) | 1.89501787 |
| 115 | Abnormal number of incisors (HP:0011064) | 1.87942307 |
| 116 | Hypoparathyroidism (HP:0000829) | 1.87080668 |
| 117 | Recurrent viral infections (HP:0004429) | 1.86697471 |
| 118 | Nonimmune hydrops fetalis (HP:0001790) | 1.86599244 |
| 119 | Granulocytopenia (HP:0001913) | 1.85797617 |
| 120 | Recurrent fungal infections (HP:0002841) | 1.85779290 |
| 121 | Urethral obstruction (HP:0000796) | 1.85361272 |
| 122 | Neoplasm of the pancreas (HP:0002894) | 1.84172460 |
| 123 | Gout (HP:0001997) | 1.84086002 |
| 124 | Aseptic necrosis (HP:0010885) | 1.83566593 |
| 125 | Horseshoe kidney (HP:0000085) | 1.83085963 |
| 126 | Atresia of the external auditory canal (HP:0000413) | 1.82901151 |
| 127 | Leukopenia (HP:0001882) | 1.82551064 |
| 128 | Ulnar bowing (HP:0003031) | 1.82549908 |
| 129 | Clubbing of toes (HP:0100760) | 1.82264119 |
| 130 | Exercise intolerance (HP:0003546) | 1.81935780 |
| 131 | Preauricular skin tag (HP:0000384) | 1.81898288 |
| 132 | Pustule (HP:0200039) | 1.81433090 |
| 133 | Abnormality of reticulocytes (HP:0004312) | 1.81112207 |
| 134 | Tongue fasciculations (HP:0001308) | 1.80412272 |
| 135 | Facial cleft (HP:0002006) | 1.79700286 |
| 136 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.79676689 |
| 137 | Overlapping toe (HP:0001845) | 1.79345127 |
| 138 | Myositis (HP:0100614) | 1.78661414 |
| 139 | Hyperthyroidism (HP:0000836) | 1.78214272 |
| 140 | Sparse eyelashes (HP:0000653) | 1.78211235 |
| 141 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.77935792 |
| 142 | Prostate neoplasm (HP:0100787) | 1.77328273 |
| 143 | Abnormality of the tricuspid valve (HP:0001702) | 1.76422603 |
| 144 | Personality changes (HP:0000751) | 1.75671064 |
| 145 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.74623243 |
| 146 | Poikiloderma (HP:0001029) | 1.73496719 |
| 147 | IgM deficiency (HP:0002850) | 1.73051154 |
| 148 | Muscle fiber atrophy (HP:0100295) | 1.73003085 |
| 149 | Acute encephalopathy (HP:0006846) | 1.72758705 |
| 150 | Acute necrotizing encephalopathy (HP:0006965) | 1.72748384 |
| 151 | Upper limb muscle weakness (HP:0003484) | 1.72742248 |
| 152 | Entropion (HP:0000621) | 1.72385855 |
| 153 | Exertional dyspnea (HP:0002875) | 1.71391149 |
| 154 | Progressive hearing impairment (HP:0001730) | 1.71319947 |
| 155 | Self-mutilation (HP:0000742) | 1.71171874 |
| 156 | Sloping forehead (HP:0000340) | 1.71016030 |
| 157 | Abnormality of T cell physiology (HP:0011840) | 1.71004715 |
| 158 | Myopathic facies (HP:0002058) | 1.70216906 |
| 159 | Supernumerary spleens (HP:0009799) | 1.68685266 |
| 160 | Elbow flexion contracture (HP:0002987) | 1.68409566 |
| 161 | Colon cancer (HP:0003003) | 1.68370783 |
| 162 | Orthostatic hypotension (HP:0001278) | 1.68194061 |
| 163 | Abnormal protein glycosylation (HP:0012346) | 1.67704050 |
| 164 | Abnormal glycosylation (HP:0012345) | 1.67704050 |
| 165 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.67704050 |
| 166 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.67704050 |
| 167 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.66268181 |
| 168 | Overriding aorta (HP:0002623) | 1.66060530 |
| 169 | Ureteral duplication (HP:0000073) | 1.65127977 |
| 170 | Patellar dislocation (HP:0002999) | 1.63845042 |
| 171 | Sensory axonal neuropathy (HP:0003390) | 1.63063362 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 3.85058687 |
| 2 | SMG1 | 3.57653077 |
| 3 | EIF2AK1 | 3.52373462 |
| 4 | VRK2 | 3.21302567 |
| 5 | NME2 | 2.94019929 |
| 6 | WEE1 | 2.87417415 |
| 7 | CDC7 | 2.46844947 |
| 8 | PIM2 | 2.41682565 |
| 9 | IRAK3 | 2.39754701 |
| 10 | SRPK1 | 2.22252179 |
| 11 | ICK | 2.20575214 |
| 12 | TRIB3 | 2.15309117 |
| 13 | PLK4 | 2.14154721 |
| 14 | IRAK4 | 2.12016650 |
| 15 | NEK1 | 2.01656005 |
| 16 | BLK | 1.96567684 |
| 17 | EEF2K | 1.96178915 |
| 18 | RPS6KA4 | 1.92958202 |
| 19 | STK16 | 1.92443251 |
| 20 | MAP4K1 | 1.92075560 |
| 21 | TESK2 | 1.83695783 |
| 22 | TLK1 | 1.79985794 |
| 23 | EIF2AK3 | 1.79703894 |
| 24 | NEK2 | 1.78580546 |
| 25 | PBK | 1.78347752 |
| 26 | ACVR1B | 1.66063476 |
| 27 | VRK1 | 1.65028654 |
| 28 | TSSK6 | 1.64482065 |
| 29 | TTK | 1.60344145 |
| 30 | EPHA2 | 1.58669526 |
| 31 | CDK7 | 1.58137550 |
| 32 | MKNK1 | 1.57686022 |
| 33 | PLK1 | 1.54730779 |
| 34 | BRSK2 | 1.52489258 |
| 35 | ARAF | 1.49986913 |
| 36 | EIF2AK2 | 1.48335910 |
| 37 | DYRK3 | 1.45285829 |
| 38 | MAP3K14 | 1.41469711 |
| 39 | IKBKB | 1.40438173 |
| 40 | MKNK2 | 1.34335616 |
| 41 | ATR | 1.31514831 |
| 42 | TBK1 | 1.29538897 |
| 43 | STK10 | 1.28159201 |
| 44 | * AURKB | 1.24353936 |
| 45 | MST1R | 1.23954445 |
| 46 | MAP3K11 | 1.23850016 |
| 47 | TXK | 1.23640935 |
| 48 | SIK1 | 1.21365378 |
| 49 | PRPF4B | 1.17290382 |
| 50 | PIM1 | 1.15998497 |
| 51 | MAP3K8 | 1.14628144 |
| 52 | ZAK | 1.13434209 |
| 53 | PASK | 1.12692955 |
| 54 | STK4 | 1.12360875 |
| 55 | NME1 | 1.10825303 |
| 56 | KDR | 1.10295874 |
| 57 | LATS2 | 1.06067229 |
| 58 | JAK3 | 1.05017020 |
| 59 | MST4 | 1.04086933 |
| 60 | CDK4 | 1.03835004 |
| 61 | CHEK2 | 1.03595242 |
| 62 | IKBKE | 1.01825597 |
| 63 | BRAF | 1.01172482 |
| 64 | PDK2 | 0.98581650 |
| 65 | CDK12 | 0.98399793 |
| 66 | PLK3 | 0.98191697 |
| 67 | TESK1 | 0.97860237 |
| 68 | ZAP70 | 0.94907755 |
| 69 | PIK3CG | 0.93180688 |
| 70 | TYK2 | 0.91483996 |
| 71 | AURKA | 0.90832872 |
| 72 | CHUK | 0.86104040 |
| 73 | PTK2 | 0.85718803 |
| 74 | MAP2K3 | 0.85289838 |
| 75 | ILK | 0.85079381 |
| 76 | RPS6KB2 | 0.84975136 |
| 77 | BCKDK | 0.84885070 |
| 78 | MTOR | 0.82552343 |
| 79 | ABL2 | 0.82257209 |
| 80 | TAF1 | 0.80488530 |
| 81 | CHEK1 | 0.80156800 |
| 82 | PAK4 | 0.79908131 |
| 83 | NEK9 | 0.79566317 |
| 84 | AKT2 | 0.76667321 |
| 85 | DAPK1 | 0.72794505 |
| 86 | TEC | 0.72018574 |
| 87 | SCYL2 | 0.70217188 |
| 88 | PAK1 | 0.70037606 |
| 89 | KIT | 0.68746499 |
| 90 | TAOK2 | 0.68590304 |
| 91 | LYN | 0.67255872 |
| 92 | ALK | 0.67142738 |
| 93 | FLT3 | 0.66766898 |
| 94 | PAK2 | 0.66628396 |
| 95 | TAOK3 | 0.66034621 |
| 96 | BRSK1 | 0.63789564 |
| 97 | RAF1 | 0.63417354 |
| 98 | CDK9 | 0.63260698 |
| 99 | STK38L | 0.62933817 |
| 100 | CSNK2A1 | 0.62606498 |
| 101 | STK3 | 0.61987299 |
| 102 | BTK | 0.61659616 |
| 103 | CCNB1 | 0.60736180 |
| 104 | ATM | 0.60057357 |
| 105 | LIMK1 | 0.57949599 |
| 106 | MARK3 | 0.57190237 |
| 107 | ERN1 | 0.56244281 |
| 108 | CDK2 | 0.55177029 |
| 109 | IRAK1 | 0.55066318 |
| 110 | TGFBR1 | 0.54887449 |
| 111 | ERBB4 | 0.54435770 |
| 112 | CDK1 | 0.54183549 |
| 113 | PRKCI | 0.54135542 |
| 114 | MAP3K9 | 0.53127465 |
| 115 | CLK1 | 0.52899935 |
| 116 | CSNK2A2 | 0.52827433 |
| 117 | TTN | 0.52307507 |
| 118 | YES1 | 0.49137035 |
| 119 | MAP3K3 | 0.48951569 |
| 120 | RPS6KA5 | 0.48756291 |
| 121 | MAPK11 | 0.47872880 |
| 122 | CDK8 | 0.45154175 |
| 123 | MAP3K10 | 0.43953183 |
| 124 | PKN2 | 0.43305515 |
| 125 | LMTK2 | 0.42252628 |
| 126 | MAP3K5 | 0.41968040 |
| 127 | PRKD3 | 0.41658592 |
| 128 | CSF1R | 0.41556815 |
| 129 | CSK | 0.41301002 |
| 130 | LRRK2 | 0.40725084 |
| 131 | IRAK2 | 0.40532074 |
| 132 | NLK | 0.40471922 |
| 133 | DYRK2 | 0.38332959 |
| 134 | BMX | 0.38294107 |
| 135 | LCK | 0.38119407 |
| 136 | MAPKAPK2 | 0.36594485 |
| 137 | MET | 0.36275548 |
| 138 | CDK11A | 0.36109178 |
| 139 | DMPK | 0.35553481 |
| 140 | MOS | 0.35484529 |
| 141 | CSNK1E | 0.34919399 |
| 142 | CDK14 | 0.32888130 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 4.01121625 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 3.35135327 |
| 3 | Ribosome_Homo sapiens_hsa03010 | 3.31947196 |
| 4 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.31608852 |
| 5 | RNA polymerase_Homo sapiens_hsa03020 | 3.27475989 |
| 6 | Mismatch repair_Homo sapiens_hsa03430 | 3.26964429 |
| 7 | Base excision repair_Homo sapiens_hsa03410 | 2.74421684 |
| 8 | Spliceosome_Homo sapiens_hsa03040 | 2.66613151 |
| 9 | Homologous recombination_Homo sapiens_hsa03440 | 2.59174330 |
| 10 | RNA transport_Homo sapiens_hsa03013 | 2.47592323 |
| 11 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.41675261 |
| 12 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.33517304 |
| 13 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.31256605 |
| 14 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.27436984 |
| 15 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.23868793 |
| 16 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.01799636 |
| 17 | Cell cycle_Homo sapiens_hsa04110 | 1.90356460 |
| 18 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.86289135 |
| 19 | Basal transcription factors_Homo sapiens_hsa03022 | 1.66901440 |
| 20 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.66013329 |
| 21 | Carbon metabolism_Homo sapiens_hsa01200 | 1.59470077 |
| 22 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.53939638 |
| 23 | RNA degradation_Homo sapiens_hsa03018 | 1.51203971 |
| 24 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.50768965 |
| 25 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.42638999 |
| 26 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.41366866 |
| 27 | Legionellosis_Homo sapiens_hsa05134 | 1.37956281 |
| 28 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.27988966 |
| 29 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.27498583 |
| 30 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.26475117 |
| 31 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.26022150 |
| 32 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.24918312 |
| 33 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.23517285 |
| 34 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.20989359 |
| 35 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.20565479 |
| 36 | Allograft rejection_Homo sapiens_hsa05330 | 1.18576436 |
| 37 | Leishmaniasis_Homo sapiens_hsa05140 | 1.17458543 |
| 38 | Purine metabolism_Homo sapiens_hsa00230 | 1.12341011 |
| 39 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.11696027 |
| 40 | Measles_Homo sapiens_hsa05162 | 1.10717209 |
| 41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.10314978 |
| 42 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.08536910 |
| 43 | Bladder cancer_Homo sapiens_hsa05219 | 1.07954204 |
| 44 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.07694311 |
| 45 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.03465638 |
| 46 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.03276908 |
| 47 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.02944925 |
| 48 | Asthma_Homo sapiens_hsa05310 | 0.97851632 |
| 49 | Parkinsons disease_Homo sapiens_hsa05012 | 0.94168766 |
| 50 | Protein export_Homo sapiens_hsa03060 | 0.93175397 |
| 51 | Apoptosis_Homo sapiens_hsa04210 | 0.92095379 |
| 52 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.89046955 |
| 53 | Influenza A_Homo sapiens_hsa05164 | 0.87940409 |
| 54 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.87783825 |
| 55 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.86110955 |
| 56 | Shigellosis_Homo sapiens_hsa05131 | 0.82981178 |
| 57 | Sulfur relay system_Homo sapiens_hsa04122 | 0.82691245 |
| 58 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.82020407 |
| 59 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.77298484 |
| 60 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.74469468 |
| 61 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.71887782 |
| 62 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.71601240 |
| 63 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.71338815 |
| 64 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.71006093 |
| 65 | Malaria_Homo sapiens_hsa05144 | 0.70753006 |
| 66 | Pertussis_Homo sapiens_hsa05133 | 0.69310209 |
| 67 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.67588484 |
| 68 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.67480448 |
| 69 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.66449332 |
| 70 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.66204175 |
| 71 | HTLV-I infection_Homo sapiens_hsa05166 | 0.65871713 |
| 72 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.63682317 |
| 73 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.63231571 |
| 74 | Viral myocarditis_Homo sapiens_hsa05416 | 0.61245671 |
| 75 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.60829580 |
| 76 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.60463330 |
| 77 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.58978567 |
| 78 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.58142846 |
| 79 | Hepatitis B_Homo sapiens_hsa05161 | 0.57640920 |
| 80 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.56687108 |
| 81 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.55852715 |
| 82 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.54163831 |
| 83 | Other glycan degradation_Homo sapiens_hsa00511 | 0.52499444 |
| 84 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.51664804 |
| 85 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.51577926 |
| 86 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.51562520 |
| 87 | Salmonella infection_Homo sapiens_hsa05132 | 0.51415955 |
| 88 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.51313079 |
| 89 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.50722941 |
| 90 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.50531407 |
| 91 | Tuberculosis_Homo sapiens_hsa05152 | 0.50256496 |
| 92 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.49390458 |
| 93 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.48757653 |
| 94 | Metabolic pathways_Homo sapiens_hsa01100 | 0.47645772 |
| 95 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.47611334 |
| 96 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.47262977 |
| 97 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.47232901 |
| 98 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.46999140 |
| 99 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.46333650 |
| 100 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.45742951 |
| 101 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.44690455 |
| 102 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.44506836 |
| 103 | Lysine degradation_Homo sapiens_hsa00310 | 0.44502858 |
| 104 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.43222826 |
| 105 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.43095870 |
| 106 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.42663961 |
| 107 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.41723255 |
| 108 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.41599135 |
| 109 | Alzheimers disease_Homo sapiens_hsa05010 | 0.40634728 |
| 110 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.40608286 |
| 111 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.40594487 |
| 112 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.38861489 |
| 113 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.38234267 |
| 114 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.36990922 |
| 115 | Huntingtons disease_Homo sapiens_hsa05016 | 0.35881475 |
| 116 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.35859136 |
| 117 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.34250763 |
| 118 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.33898858 |
| 119 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.33262115 |
| 120 | Galactose metabolism_Homo sapiens_hsa00052 | 0.32404698 |
| 121 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.32343742 |
| 122 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.32309580 |
| 123 | Phagosome_Homo sapiens_hsa04145 | 0.31107471 |
| 124 | Thyroid cancer_Homo sapiens_hsa05216 | 0.31032225 |
| 125 | Prion diseases_Homo sapiens_hsa05020 | 0.30456856 |
| 126 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.29958190 |
| 127 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.29327115 |
| 128 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.28837961 |
| 129 | Hepatitis C_Homo sapiens_hsa05160 | 0.28433468 |
| 130 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.27662663 |
| 131 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.27637635 |
| 132 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.27032425 |
| 133 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.24238366 |
| 134 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.24178546 |
| 135 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.23250313 |
| 136 | Prostate cancer_Homo sapiens_hsa05215 | 0.23171264 |
| 137 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.22956062 |
| 138 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.22703539 |
| 139 | Lysosome_Homo sapiens_hsa04142 | 0.22642719 |
| 140 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.22358104 |
| 141 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.22272923 |
| 142 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.21791256 |
| 143 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.21125711 |
| 144 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.20294844 |
| 145 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.19190569 |

